Anlima Yarn Dyeing Limited (DSE:ANLIMAYARN)

SpringWorks Therapeutics Income Statement

Financials in millions BDT. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Revenue	101.73	139.23	162.3	155.57	155.03	154.39
Revenue Growth (YoY)	-38.95%	-14.21%	4.33%	0.35%	0.41%	-7.58%
Cost of Revenue	151.89	164.56	140.79	144.26	136.42	134.44
Gross Profit	-50.16	-25.32	21.51	11.31	18.61	19.95
Selling, General & Admin	17.29	17.78	18.76	18.35	17.23	16.77
Operating Expenses	17.29	17.78	18.76	18.35	17.23	16.77
Operating Income	-67.45	-43.1	2.75	-7.04	1.38	3.19
Currency Exchange Gain (Loss)	6.25	14.74	0.54	4.2	0.3	0.65
Other Non Operating Income (Expenses)	-1.19	-0.67	-1.29	-0.64	-0.69	-0.75
Pretax Income	-62.39	-29.03	2	-3.48	1	3.09
Income Tax Expense	-1.02	3.21	0.55	-0.21	0.17	0.53
Net Income	-61.37	-32.24	1.45	-3.26	0.83	2.56
Net Income to Common	-61.37	-32.24	1.45	-3.26	0.83	2.56
Net Income Growth	-	-	-	-	-67.74%	-72.41%
Shares Outstanding (Basic)	18	18	18	18	18	18
Shares Outstanding (Diluted)	18	18	18	18	18	18
EPS (Basic)	-3.43	-1.80	0.08	-0.18	0.05	0.14
EPS (Diluted)	-3.43	-1.80	0.08	-0.18	0.05	0.14
EPS Growth	-	-	-	-	-67.74%	-72.41%
Free Cash Flow	-16.24	3.99	-27.4	17.48	7.85	13.52
Free Cash Flow Per Share	-0.91	0.22	-1.53	0.98	0.44	0.76
Dividend Per Share	-	-	-	-	0.200	0.200
Dividend Growth	-	-	-	-	-	-60.00%
Gross Margin	-49.31%	-18.19%	13.25%	7.27%	12.01%	12.93%
Operating Margin	-66.31%	-30.96%	1.69%	-4.52%	0.89%	2.07%
Profit Margin	-60.32%	-23.16%	0.89%	-2.10%	0.53%	1.66%
Free Cash Flow Margin	-15.96%	2.87%	-16.88%	11.24%	5.06%	8.76%
EBITDA	-54.77	-29.76	15.76	6.25	15.63	18.48
EBITDA Margin	-53.84%	-21.38%	9.71%	4.02%	10.08%	11.97%
D&A For EBITDA	12.68	13.34	13.01	13.29	14.25	15.29
EBIT	-67.45	-43.1	2.75	-7.04	1.38	3.19
EBIT Margin	-66.31%	-30.96%	1.69%	-4.52%	0.89%	2.07%
Effective Tax Rate	-	-	27.50%	-	17.26%	17.09%
Advertising Expenses	-	0.05	0.2	0.11	0.1	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.